Total IP	40
Total IP Rank #	35,039
IP Activity Score	2.6/5.0    50
IP Activity Rank #	14,641
Dominant Nice Class	Pharmaceutical, veterinary and s...

Patents Trademarks 17 1 4 1 16 1 0
Last Patent	2025 - Her3 antigen-binding molecules
First Patent	2018 - Cd47 antigen-binding molecules
Last Trademark	2022 - HUMMINGBIRD BIOSCIENCE
First Trademark	2021 - Hummingbird Bioscience

Industry (Nice Classification)

Latest Inventions, Goods, Services 2024 Invention Her3 antigen-binding molecules. HER3 antigen-binding molecules are disclosed. Also disclosed are... Invention Methods for antibody production. The present disclosure relates to the production of antigen-bind... Invention Combination for treatment and prevention of cancer. The present disclosure provides methods for t... Invention Treatment and prevention of cancer using her3 antigen-binding molecules. The present disclosure p... Invention Vh4-34 antigen-binding molecules. Provided herein are VH4-34 antigen binding molecules (e.g., VH4... Invention Her3-binding antibody-drug conjugate. Methods of treating cancer are provided, as well as compos... Invention Her3-binding antibody-drug conjugate. Methods of treating cancer are provided, as well as composi... 2023 Invention Combination of 10d1f and an androgen inhibitor for treatment and prevention of cancers. Methods f... Invention Vista antigen-binding molecules. VISTA antigen-binding molecules are disclosed. Also disclosed a... Invention Treatment and prevention of cancer using vista antigen-binding molecules. VISTA antigen-binding m... 2022 Invention Treatment and prevention of cancer using vista antigen-binding molecules. The present disclosure ... Invention Cd47 antigen-binding molecules. CD47 antigen-binding molecules are disclosed. Also disclosed are ... Invention Cells expressing vista antigen-binding molecules. Cells expressing VISTA antigen-binding molecul... Invention Cells expressing her3 antigen-binding molecules. Cells expressing HER3 antigen-binding molecules... Invention Cells expressing her3 antigen-binding molecules. Cells expressing HER3 antigen-binding molecules ... Invention Cells expressing vista antigen-binding molecules. Cells expressing VISTA antigen-binding molecule... G/S Pharmaceutical preparations for the prevention, diagnosis, and treatment of oncological and immun... 2021 Invention Bcma/taci antigen-binding molecules. BCMA/TACI antigen-binding molecules are disclosed. Also dis... Invention Bcma/taci antigen-binding molecules. BCMA/TACI antigen-binding molecules are disclosed. Also disc... G/S Pharmaceutical preparations for the prevention, diagnosis, and treatment of diseases for scienti... G/S Monoclonal antibodies for the prevention, diagnosis, and treatment of cancer and auto-immune dise... Invention Treatment and prevention of cancer using her3 antigen-binding molecules. Methods for treating or ... 2020 Invention Vista antigen-binding molecules. VISTA antigen-binding molecules are disclosed. Also disclosed ar... Invention Her3 antigen-binding molecules. HER3 antigen-binding molecules are disclosed. Also disclosed are ... 2019 Invention Engineered fc. Antigen-binding molecules comprising an Fc region comprising a polypeptide having... 2018 Invention Cd47 antigen-binding molecules. CD47 antigen-binding molecules are disclosed. Also disclosed are...